Clinical Pathways
Clinical Pathways
CT is indicated before LP
CT is indicated before LP

CT is indicated before LP

View The Full Pathway

Action

  • Administer empiric IV antimicrobials guided by patient risk factors (See Table 6) (Class I)
  • Administer dexamethasone 0.15 mg/ kg IV q6 hours (Class II)
  • Perform CT of brain (Class II)

Decision

Contraindication to LP or alternative diagnosis identified on CT?

icon
Yes → Discuss with specialist (eg, neurology, neurosurgery)

Background

image

‣
References
  1. *van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22:S37-S62. (Practice guideline) DOI: 10.1016/j.cmi.2016.01.007
  2. Brouwer MC, van de Beek D. Epidemiology of community-acquired bacterial meningitis. Curr Opin Infect Dis. 2018;31(1):78-84. (Review)
  3. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993;328(1):21-28. (Retrospective; 493 cases, 445 patients)
  4. Bijlsma MW, Brouwer MC, Kasanmoentalib ES, et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis. 2016;16(3):339-347. (Prospective observational; 1412 patients)
  5. Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364(21):2016-2025. (Retrospective observational; 3155 patients)
  6. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351(18):1849-1859. (Retrospective; 696 cases)
  7. Manyelo CM, Solomons RS, Walzl G, et al. Tuberculous meningitis: pathogenesis, immune responses, diagnostic challenges, and the potential of biomarker-based approaches. J Clin Microbiol. 2021;59(3):e01771-e01720. (Review)
  8. van de Beek D, Brouwer MC, Koedel U, et al. Community-acquired bacterial meningitis. Lancet 2021;398(10306):1171-1183. (Review) 
  9. Hasbun R. Update and advances in community acquired bacterial meningitis. Curr Opin Infect Dis. 2019;32(3):233-238. (Review) 
  10. Granerod J, Tam CC, Crowcroft NS, et al. Challenge of the unknown. A systematic review of acute encephalitis in non-outbreak situations. Neurology. 2010;75(10):924-932. (Systematic review; 44 studies) 
  11. Beaman MH. Community-acquired acute meningitis and encephalitis: a narrative review. Med J Aust. 2018;209(10):449- 454. (Review)
  12. * Wright WF, Pinto CN, Palisoc K, et al. Viral (aseptic) meningitis: a review. J Neurol Sci. 2019;398:176-183. (Review) DOI: 10.1016/j.jns.2019.01.050 
  13. Peigue-Lafeuille H, Croquez N, Laurichesse H, et al. Enterovirus meningitis in adults in 1999-2000 and evaluation of clinical management. J Med Virol. 2002;67(1):47-53. (Prospective observational; 30 patients) 
  14. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986;314(3):144-149. (Randomized controlled trial; 208 patients) 
  15. Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006;43(12):1565-1577. (Prospective observational; 1570 patients)
  16. George BP, Schneider EB, Venkatesan A. Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010. PLoS One. 2014;9(9):e104169. (Retrospective observational; 238,567 patients) 
  17. * Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the International Encephalitis Consortium. Clin Infect Dis. 2013;57(8):1114-1128. (Practice guideline) DOI: 10.1093/cid/cit458
  18. Huo L, Xu KL, Wang H. Clinical features of SARS-CoV-2-associated encephalitis and meningitis amid COVID-19 pandemic. World J Clin Cases. 2021;9(5):1058-1078. (Case series; 32 patients) 
  19. Antoniello D, Milstein MJ, Dardick J, et al. Altered mental status in COVID-19. J Neurol. 2022;269(1):12-18. (Retrospective; 166 patients) 
  20. Aksamit AJ. Treatment of viral encephalitis. Neurol Clin. 2021;39(1):197-207. (Review) 
  21. Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23(4):525-530. (Review) 
  22. * Attia J, Hatala R, Cook DJ, et al. The rational clinical examination. Does this adult patient have acute meningitis? JAMA. 1999;282(2):175-181. (Systematic review; 10 studies) DOI: 10.1001/jama.282.2.175 
  23. Gaieski DF, O’Brien NF, Hernandez R. Emergency neurologic life support: meningitis and encephalitis. Neurocrit Care. 2017;27(Suppl 1):124-133. (Practice guideline) 
  24. Seymour CW, Cooke CR, Heckbert SR, et al. Prehospital intravenous access and fluid resuscitation in severe sepsis: an observational cohort study. Crit Care (London). 2014;18(5):533. (Prospective; 15 centers, 1350 patients) 
  25. * Julián-Jiménez A, Morales-Casado MI. Usefulness of blood and cerebrospinal fluid laboratory testing to predict bacterial meningitis in the emergency department. Neurologica (Engl Ed). 2019;34(2):105-113. (Review) DOI: 10.1016/j.nrl.2016.05.009 
  26. Sakushima K, Hayashino Y, Kawaguchi T, et al. Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: a meta-analysis. J Infect. 2011;62(4):255-262. (Meta-analysis; 33 studies, 1885 patients)
  27. * McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016;72(4):405-438. (Practice guideline) DOI: 10.1016/j.jinf.2016.01.007
  28. Briere EC, Rubin L, Moro PL, et al. Prevention and control of Haemophilus influenzae type B disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2014;63(Rr-01):1-14. (Guidelines) 
  29. U.S. Centers for Disease Control and Prevention. Updated recommendations for use of VariZIG --United States, 2013. MMWR Recomm Rep. 2013;62(28):574-576. (Practice guideline) 
  30. Cohn AC, MacNeil JR, Clark TA, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Reomm Rep. 2013;62(RR-2):1-28. (Practice guideline) 
  31. Bardak-Ozcem S, Sipahi OR. An updated approach to healthcare-associated meningitis. Expert Rev Anti Infect Ther. 2014;12(3):333-342. (Review) 
  32. Tyler KL. Acute viral encephalitis. N Engl J Med. 2018;379(6):557-566. (Review) 
  33. Kenfak A, Eperon G, Schibler M, et al. Diagnostic approach to encephalitis and meningoencephalitis in adult returning travellers. Clin Microbiol Infect. 2019;25(4):415-421. (Review) 
  34. Brody IA, Wilkins RH. The signs of Kernig and Brudzinski. Arch Neurol. 1969;21(2):215-218. (Editorial) 
  35. Nakao JH, Jafri FN, Shah K, et al. Jolt accentuation of headache and other clinical signs: poor predictors of meningitis in adults. Am J Emerg Med. 2014;32(1):24-28. (Prospective observational; 197 patients) 
  36. Uchihara T, Tsukagoshi H. Jolt accentuation of headache: the most sensitive sign of CSF pleocytosis. Headache. 1991;31(3):167-171. (Prospective; 54 patients) 
  37. Iguchi M, Noguchi Y, Yamamoto S, et al. Diagnostic test accuracy of jolt accentuation for headache in acute meningitis in the emergency setting. Cochrane Database Syst Rev. 2020;6:CD012824. (Cochrane review and meta-analysis; 9 studies, 1161 patients) 
  38. Nigrovic LE, Malley R, Macias CG, et al. Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis. Pediatrics. 2008;122(4):726-730. (Retrospective; 245 patients)
  39. * Costerus JM, Brouwer MC, Bijlsma MW, et al. Community-acquired bacterial meningitis. Curr Opin Infect Dis. 2017;30(1):135-141. (Review) DOI: 10.1097/QCO.0000000000000335 
  40. Bonadio WA. The cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis. Pediatr Infect Dis J. 1992;11(6):423-431. (Review) 
  41. Ellis J, Luintel A, Chandna A, et al. Community-acquired acute bacterial meningitis in adults: a clinical update. Br Med Bull. 2019;131(1):57-70. (Review) 
  42. Arevalo CE, Barnes PF, Duda M, et al. Cerebrospinal fluid cell counts and chemistries in bacterial meningitis. South Med J. 1989;82(9):1122-1127. (Retrospective; 428 patients) 
  43. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267-1284. (Practice guideline) 
  44. Dumaidi K, Al-Jawabreh A. Molecular detection and genotyping of enteroviruses from CSF samples of patients with suspected sepsis-like illness and/or aseptic meningitis from 2012 to 2015 in West Bank, Palestine. PloS One. 2017;12(2):e0172357. (Prospective; 356 patients) 
  45. Mazor SS, McNulty JE, Roosevelt GE. Interpretation of traumatic lumbar punctures: who can go home? Pediatrics. 2003;111(3):525-528. (Retrospective; 57 patients) 
  46. Dougherty JM, Roth RM. Cerebral spinal fluid. Emerg Med Clin N Amer. 1986;4(2):281-297. (Review)
  47. Tamune H, Takeya H, Suzuki W, et al. Cerebrospinal fluid/ blood glucose ratio as an indicator for bacterial meningitis. Am J Emerg Med. 2014;32(3):263-266. (Retrospective; 144 patients) 
  48. Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics. 2001;108(5):1169-1174. (Retrospective; 128 patients) 
  49. Baheerathan A, Pitceathly RD, Curtis C, et al. CSF lactate. Pract Neurol. 2020;20(4):320-323. (Review)
  50. Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017;64(6):e34-e65. (Practice guideline) 
  51. Buch K, Bodilsen J, Knudsen A, et al. Cerebrospinal fluid lactate as a marker to differentiate between community-acquired acute bacterial meningitis and aseptic meningitis/encephalitis in adults: a Danish prospective observational cohort study. Infect Dis (Lond). 2018;50(7):514-521. (Prospective; 176 patients) 
  52. Verstrepen WA, Kuhn S, Kockx MM, et al. Rapid detection of enterovirus RNA in cerebrospinal fluid specimens with a novel single-tube real-time reverse transcription-PCR assay. J Clin Microbiol. 2001;39(11):4093-4096. (Prospective; 70 patients) 
  53. Bahr NC, Meintjes G, Boulware DR. Inadequate diagnostics: the case to move beyond the bacilli for detection of meningitis due to Mycobacterium tuberculosis. J Med Microbiol. 2019;68(5):755-760. (Review) 
  54. Hernandez AV, de Laurentis L, Souza I, et al. Diagnostic accuracy of Xpert MTB/RIF for tuberculous meningitis: systematic review and meta-analysis. Trip Med Int Health. 2021;26(2):122- 132. (Meta-analysis; 30 articles, 3972 cases) 
  55. Morales-Casado MI, Julián-Jiménez A, Moreno-Alonso F, et al. [Diagnostic usefulness of procalcitonin and C-reactive protein in the emergency department for predicting bacterial meningitis in the elderly]. Enferm Infecc Microbiol Clin. 2016;34(1):8-16. (Prospective; 220 patients) 
  56. Chalupa P, Beran O, Herwald H, et al. Evaluation of potential biomarkers for the discrimination of bacterial and viral infections. Infection. 2011;39(5):411-417. (Prospective; 81 patients) 
  57. Vikse J, Henry BM, Roy J, et al. The role of serum procalcitonin in the diagnosis of bacterial meningitis in adults: a systematic review and meta-analysis. Int J Infect Dis. 2015;38:68-76. (Meta-analysis; 9 studies, 725 patients) 
  58. Newcombe J, Cartwright K, Palmer WH, et al. PCR of peripheral blood for diagnosis of meningococcal disease. J Clin Microbiol. 1996;34(7):1637-1640. (Prospective; 80 patients) 
  59. Temfack E, Rim JJB, Spijker R, et al. Cryptococcal antigen in serum and cerebrospinal fluid for detecting cryptococcal meningitis in adults living with human immunodeficiency virus: systematic review and meta-analysis of diagnostic test accuracy studies. Clin Infect Dis. 2021;72(7):1268-1278. (Meta-analysis; 11 studies, 3600 patients) 
  60. Venkatesan A, Jagdish B. Imaging in encephalitis. Semin Neurol. 2019;39(3):312-321. (Review) 
  61. Glimåker M, Johansson B, Bell M, et al. Early lumbar puncture in adult bacterial meningitis--rationale for revised guidelines. Scand J Infect Dis. 2013;45(9):657-663. (Review)
  62. Costerus JM, Brouwer MC, Sprengers MES, et al. Cranial computed tomography, lumbar puncture, and clinical deterioration in bacterial meningitis: a nationwide cohort study. Clin Infect Dis. 2018;67(6):920-926. (Retrospective; 1533 patients) 
  63. Bertrand A, Leclercq D, Martinez-Almoyna L, et al. MR imaging of adult acute infectious encephalitis. Med Mal Infect. 2017;47(3):195-205. (Review) 
  64. Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med. 1998;129(11):862-869. (Retrospective; 269 patients) 
  65. Proulx N, Fréchette D, Toye B, et al. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM. 2005;98(4):291-298. (Retrospective case record study; 119 patients) 
  66. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(3):291-322. (Practice guideline) 
  67. van de Beek D, Brouwer MC, Thwaites GE, et al. Advances in treatment of bacterial meningitis. Lancet. 2012;380(9854):1693- 1702. (Review) 
  68. Poulsen KP, Czuprynski CJ. Pathogenesis of listeriosis during pregnancy. Anim Health Res Rev. 2013;14(1):30-39. (Review) 
  69. Pelegrín I, Moragas M, Suárez C, et al. Listeria monocytogenes meningoencephalitis in adults: analysis of factors related to unfavourable outcome. Infection. 2014;42(5):817-827. (Retrospective; 59 patients) 
  70. Kitonsa J, Nsubuga R, Mayanja Y, et al. Determinants of two-year mortality among HIV positive patients with cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda. PLoS Negl Trop Dis. 2020;14(11):e0008823. (Retrospective; 211 patients) 
  71. Tenforde MW, Shapiro AE, Rouse B, et al. Treatment for HIV-associated cryptococcal meningitis. Cochrane Database Syst Rev. 2018;7:CD005647. (Cochrane review, meta-analysis; 13 studies, 2426 patients) 
  72. Bradshaw MJ, Venkatesan A. Herpes simplex virus-1 encephalitis in adults: pathophysiology, diagnosis, and management. Neurotherapeutics. 2016;13(3):493-508. (Review) 
  73. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47(3):303-327. (Practice guidelines) 
  74. * Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015(9):CD004405. (Cochrane review, meta-analysis; 25 studies, 4121 patients) DOI: 10.1002/14651858.CD004405.pub5 
  75. Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016;4:CD002244. (Cochrane review, meta-analysis; 9 studies, 1337 patients) 
  76. Glimåker M, Brink M, Naucler P, et al. Betamethasone and dexamethasone in adult community-acquired bacterial meningitis: a quality registry study from 1995 to 2014. Clin Microbiol Infect. 2016;22(9):814.e811-e814. (Retrospective; 1746 patients) 
  77. Armangue T, Spatola M, Vlagea A, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet. Neurol. 2018;17(9):760-772. (Prospective; 99 patients) 
  78. Joubert B, Dalmau J. The role of infections in autoimmune encephalitides. Rev Neurol (Paris). 2019;175(7-8):420-426. (Review) 
  79. McLean HQ, Fiebelkorn AP, Temte JL, et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62(RR-04):1-34. (Practice guideline) 
  80. Garg RK, Mahadevan A, Malhotra HS, et al. Subacute sclerosing panencephalitis. Rev Med Virol. 2019;29(5):e2058. (Review) 
  81. Wall EC, Ajdukiewicz KM, Bergman H, et al. Osmotic therapies added to antibiotics for acute bacterial meningitis. Cochrane Database Syst Rev. 2018;2:CD008806. (Cochrane review, meta-analysis; 5 studies, 1451 patients)
  82. Mourvillier B, Tubach F, van de Beek D, et al. Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA. 2013;310(20):2174-2183. (Randomized controlled trial; 98 patients) 
  83. Fan S-J, Tan H-K, Xu Y-C, et al. A pooled analysis of the LAMP assay for the detection of Neisseria meningitidis. BMC Infect Dis. 2020;20(1):525. (Systematic review; 14 studies, 3185 patients) 
  84. Tansarli GS, Chapin KC. Diagnostic test accuracy of the BioFire® FilmArray® meningitis/encephalitis panel: a systematic review and meta-analysis. Clin Microbiol Infect. 2020;26(3):281- 290. (Meta-analysis; 8 studies, 3059 patients) 
  85. Nigrovic LE, Kuppermann N, Macias CG, et al. Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk of bacterial meningitis. JAMA. 2007;297(1):52-60. (Retrospective; 20 centers, 3295 patients)

No Contraindication to LP
No Contraindication to LP
FacebookTwitterLinkedInInstagramYouTubePinterest

EB Medicine

FOAMed

Podcast

© EB Medicine. All rights reserved